Ocular Therapeutix Inc (OCUL): Ask is super thin wont take much to move...

Tzr250rg · 2023-01-19T19:51:45.7030000Z

Ask is super thin wont take much to move. GLTUA

Play Episode

4min

Proactive - Interviews for investors

Gunnison Copper advances Johnson Camp Mine construction, on track for Cathode Production in Q3 2025

Gunnison Copper SVP- Operations Robert Winton joined Steve Darling from Proactive to provide an update on the ongoing construction progress at the fully permitted Johnson Camp Mine in southeast Arizona. Speaking with Proactive, Winton confirmed that construction activities are on schedule, with the company expecting to produce copper cathode by Q3 2025. Mining of mineralized material officially began in January 2025, and the extracted material is currently being stockpiled in preparation for the completion of the leach pad. The Phase-1 leach pad has been successfully completed, while Phase-2 is advancing rapidly. Once Phase-2 is in place, the company will begin installing Nuton’s advanced processing equipment, a key step toward optimizing sulfide and oxide mineralized material processing. Gunnison Copper has also completed the redesign and construction of a state-of-the-art laboratory for on-site material and process analysis. The lab is set to begin ramping up in April 2025 and will be fully commissioned once leach pad production is underway. Additionally, the company’s HR team is making significant strides in building a strong workforce, with an emphasis on local hiring. Gunnison Copper has already brought in exceptional talent, reinforcing its commitment to both operational excellence and community engagement. With these developments, Gunnison Copper remains on track to deliver sustainable copper production, leveraging innovative technologies and a highly skilled team to drive success at Johnson Camp Mine. #proactiveinvestors #gunnisoncoppercorp #tsx #gcu #otcqb #gcumf #mining #johnsoncampmine GunnisonCopper #NutonTechnology #JohnsonCamp #CriticalMinerals #MadeInAmericaCopper #HeapLeaching #MiningUpdate #RioTintoPartnership #CopperSupplyChain #Q2MiningOutlook

Proactive - Interviews for investors

Alpha HPA eyes global demand with stage 2 facility

Alpha HPA Ltd Managing Director Rob Williamson talked with Proactive at the AIM Small and Midcap conference about how the company is redefining aluminum purification through its novel solvent extraction technology. Alpha HPA is producing high-purity aluminum materials for advanced industries such as semiconductors, lithium-ion batteries, direct lithium extraction, and LED technologies. Williamson explained that while solvent extraction has been used in industries like copper and rare earths, Alpha HPA is the first to apply it to aluminum purification, allowing for significantly reduced energy input and improved sustainability. Williamson said, “We can produce our materials at a 70% lower carbon footprint compared to incumbent manufacturers.” This aligns with growing global demand for cleaner technologies and supports the energy transition. The company recently signed a letter of intent with a customer in the semiconductor market, targeting an alloy used in polishing silicon carbide wafers. The product is 50% more efficient than alternatives, and Williamson noted the Stage 2 facility, currently under construction, is expected to have 10,000 tonnes of annual capacity to meet rising demand. With a compelling cost structure and an average sales price of around USD 25 per kilo versus a material input cost of approximately USD 500 per tonne, Alpha HPA believes it is well-positioned for strong margins and market growth. #AlphaHPA #AluminumPurification #Semiconductors #GreenTechnology #EnergyTransition #HighPurityAluminum #CleanTech #BatteryMaterials #SustainableManufacturing #Stage2Facility

Proactive - Interviews for investors

Genflow Biosciences CEO welcomes new investment; outlines dog longevity trial

Genflow Biosciences PLC CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about a pivotal new direction for the company as it initiates a clinical trial focused on improving aging in dogs. Leire described the trial as a natural evolution from Genflow's previous success in mice, noting the commercial appeal of the canine market. “There is nothing to improve really the quality of life of our aging dogs,” he said, adding that the study meets a significant unmet need. The trial will run for one year, with six months of treatment followed by six months of assessment. It's being managed by independent contract research organisation Syngene. Leire emphasised the scientific rigour of the trial, which is controlled, randomised and includes both aesthetic and biological endpoints. These include coat quality, mitochondrial function, and methylation clocks — all of which have potential crossover value for human applications. Leire also highlighted the company’s differentiated approach compared to US competitors using repurposed drugs like metformin. Genflow, he said, is pursuing gene therapy with the potential for greater impact. The investment supporting the trial, although limited in size, is seen as a strategic vote of confidence, bringing in credible investors from outside the UK, including the US. Leire described the initiative as a major step that could generate near-term revenue and redefine the company’s biotech positioning. For more company updates, visit Proactive's YouTube channel. Don’t forget to like the video, subscribe to the channel, and hit the notification bell for future content. #GenflowBiosciences #GeneTherapy #DogAging #BiotechInvestment #LongevityResearch #Mitochondria #PetHealth #ClinicalTrials #AgingDogs #BiotechNews

Proactive - Interviews for investors

Airtasker CEO on growth, AI & global expansion

Airtasker Ltd CEO Tim Fung talked with Proactive at AIM's Small and Midcap Conference about the company’s strategic focus across innovation, growth, and international expansion.** Fung outlined how Airtasker differentiates itself in the local services marketplace by operating as a community platform, where both customers and taskers set job scopes and pricing, rather than the company enforcing set rates. He emphasised Airtasker’s approach to worker empowerment, noting, *“The top people on our platform are running 150, 200 thousand dollars a year doing these kinds of jobs.”* Fung also acknowledged the challenges of the current consumer environment, pointing to Airtasker’s 14.8% revenue growth in the half as a result of lean operations and renewed brand investment. A key part of Airtasker’s strategy involves innovation across customer acquisition, user experience, and operational efficiency—highlighting its collaboration with OpenAI and use of AI tools like Copilot and Zendesk AI. Fung also discussed partnerships, including one with Visa Cash App Racing Bulls, as examples of how Airtasker showcases the diverse range of skilled work enabled by the platform. He concluded by outlining the investor case: a cash-generative, proven business model in Australia being used to fund international growth in the US and UK, offering upside potential with limited downside. #Airtasker #TimFung #ASX #GigEconomy #AIIntegration #MarketplacePlatform #SmallCapStocks #TechInnovation #FY25Strategy #ProactiveInvestors #OpenAI #GlobalExpansion #InvestorUpdates #StartupGrowth

Followers	23
Posts	1084
Boards Moderated	0
Alias Born	03/07/2013

Volume:	4
Day Range:
Bid:	6.99
Ask:	8.04
Last Trade Time:	4:40:39 AM EDT
Total Trades:	4

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

OCUL Detailed Quote

Recent OCUL News

More OCUL News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent OCUL News

Go Ad-Free